Alphatec Holdings, Inc.

Canaccord Genuity acts as Lead Manager for upsized US$115.0 million public offering of common stock by Alphatec Holdings, Inc.

Canaccord Genuity is pleased to announce that on October 16, 2020, it completed a public offering of common stock for
Alphatec Holdings, Inc. (NASDAQ: ATEC) (the “Company”). The Company issued a total of 13,142,855 shares of its common stock at a price to the public of $8.75 per share, which includes the full exercise of the underwriters’ overallotment option. The gross proceeds to the Company, before deducting the underwriting discounts and commissions and estimated offering expenses, were approximately $115.0 million. The Company intends to use the net proceeds from the offering for general corporate purposes, including working capital, capital expenditures and continued research and development, and to fund possible investments in or acquisitions of complementary businesses, products or technologies.

Canaccord Genuity acted as Lead Manager for the offering.

Alphatec Holdings, Inc. designs, develops and markets innovative spinal fusion technology and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Company is committed to the development and commercialization of novel technologies intended to simplify surgical procedures, provide enhanced information for surgeons and improve patient outcomes